115 related articles for article (PubMed ID: 35713138)
1. miRNA-633 and KAI1 as Potential Biomarkers of Malignant Melanoma with Gastric Cancer.
Wang ZX; Zhang GJ; Yang XF; Feng SJ; Ji SS; Qi YB
Comb Chem High Throughput Screen; 2023; 26(5):1001-1014. PubMed ID: 35713138
[TBL] [Abstract][Full Text] [Related]
2. Lower expression of KAI1 as a biomarker of poor survival prognosis of melanoma combined with colorectal cancer metastasis.
Du X; Wang B; Liu L; Li Y; Wang ZX; Zhang GJ; Yang XF
J Int Med Res; 2022 Aug; 50(8):3000605221116758. PubMed ID: 35942551
[TBL] [Abstract][Full Text] [Related]
3. The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
Lu G; Zhou L; Zhang X; Zhu B; Wu S; Song W; Gong X; Wang D; Tao Y
World J Surg Oncol; 2016 Oct; 14(1):276. PubMed ID: 27793161
[TBL] [Abstract][Full Text] [Related]
4. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.
Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D
Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923
[TBL] [Abstract][Full Text] [Related]
5. Limited value of KAI1/CD82 protein expression as a prognostic marker in human gastric cancer.
Knoener M; Krech T; Puls F; Lehmann U; Kreipe H; Christgen M
Dis Markers; 2012; 32(6):337-42. PubMed ID: 22684230
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.
Wang Y; Yang R; Wang X; Ci H; Zhou L; Zhu B; Wu S; Wang D
Medicine (Baltimore); 2018 Dec; 97(52):e13817. PubMed ID: 30593175
[TBL] [Abstract][Full Text] [Related]
7. Down Regulation of KAI1/CD82 in Lymph Node Positive and Advanced T-Stage Group in Breast Cancer Patients.
Krishna Latha T; Verma A; Thakur GK; Banerjee B; Kaur N; Singh UR; Sharma S
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3321-3329. PubMed ID: 31759355
[TBL] [Abstract][Full Text] [Related]
8. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.
Yu L; Zhou L; Wu S; Gong X; Feng Z; Ma L; Zhu B; Yao N; Wang D; Dong H
World J Surg Oncol; 2014 Apr; 12():118. PubMed ID: 24758564
[TBL] [Abstract][Full Text] [Related]
10. [Expression of metastasis suppressor gene KAI1/CD82 in cervical squamous cell carcinoma and its clinical significance].
Xiong Y; Liang LZ; Yan XJ; Yuan SH; Wei M
Ai Zheng; 2005 Jan; 24(1):110-5. PubMed ID: 15642213
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.
Guo C; Liu QG; Zhang L; Song T; Yang X
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408
[TBL] [Abstract][Full Text] [Related]
12. Expressions of KAI1 and E-cadherin in nonsmall cell lung cancer and their correlation with vasculogenic mimicry.
Ci H; Xu Z; Xu J; Wang Y; Wu S
Medicine (Baltimore); 2018 Oct; 97(40):e12293. PubMed ID: 30290593
[TBL] [Abstract][Full Text] [Related]
13. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
[TBL] [Abstract][Full Text] [Related]
14. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
Zeng TD; Zheng B; Zheng W; Chen C
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
[TBL] [Abstract][Full Text] [Related]
15. Loss of KAI1 expression in gastric cancer.
Tsutsumi S; Shimura T; Morinaga N; Mochiki E; Asao T; Kuwano H
Hepatogastroenterology; 2005; 52(61):281-4. PubMed ID: 15783050
[TBL] [Abstract][Full Text] [Related]
16. Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancer.
Christgen M; Christgen H; Heil C; Krech T; Länger F; Kreipe H; Lehmann U
Cancer Sci; 2009 Sep; 100(9):1767-71. PubMed ID: 19549254
[TBL] [Abstract][Full Text] [Related]
17. [The expression of KAI1 in gastric adenocarcinoma and relationship with angiogenesis/lymphangiogenesis].
Zhou L; Wu SW; Yu L; Song WQ; Cheng ZN; Wang DN
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jan; 45(1):43-8. PubMed ID: 24527580
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional and translational modulation of KAI1 expression in ductal carcinoma of the breast and the prognostic significance.
Malik FA; Sanders AJ; Jones AD; Mansel RE; Jiang WG
Int J Mol Med; 2009 Feb; 23(2):273-8. PubMed ID: 19148553
[TBL] [Abstract][Full Text] [Related]
20. [Expressions of Snail, Slug and KAI1 proteins in cervical carcinoma and their clinicopathological significance].
Gong X; Tao Y; Zhou L; Yu L; Wu S; Song W; Wang D; Cheng Z
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1733-8. PubMed ID: 26714907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
